AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $410,000 | -23.1% | 8,605 | -47.8% | 0.05% | -29.4% |
| Q3 2019 | $533,000 | -88.7% | 16,474 | -82.6% | 0.07% | -79.2% |
| Q2 2019 | $4,713,000 | -17.2% | 94,500 | +12.0% | 0.33% | +24.3% |
| Q1 2019 | $5,691,000 | -9.0% | 84,400 | -37.8% | 0.26% | -39.0% |
| Q4 2018 | $6,252,000 | -22.3% | 135,600 | +30.0% | 0.43% | -6.5% |
| Q3 2018 | $8,043,000 | +864.4% | 104,300 | +614.4% | 0.46% | +924.4% |
| Q4 2017 | $834,000 | -74.6% | 14,600 | -70.3% | 0.04% | -74.4% |
| Q3 2017 | $3,284,000 | -24.6% | 49,200 | -41.9% | 0.18% | -34.6% |
| Q2 2017 | $4,357,000 | +111.4% | 84,700 | +139.9% | 0.27% | +106.9% |
| Q1 2017 | $2,061,000 | -1.2% | 35,300 | -29.4% | 0.13% | -24.4% |
| Q4 2016 | $2,086,000 | +45.6% | 50,000 | +59.7% | 0.17% | -19.2% |
| Q2 2014 | $1,433,000 | – | 31,300 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |